Roy D. Baynes - 19 Nov 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Nov 2025, 20:05:05 UTC
Prior SEC filing
04 Nov 2025
Next SEC filing
03 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Vincent Fontanilla, Attorney-in-Fact

Key filing fact

Roy D. Baynes filed Form 4 for Natera, Inc. (NTRA) on 21 Nov 2025.

Key facts

  • This page summarizes Roy D. Baynes's Form 4 filing for Natera, Inc. (NTRA).
  • 14 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 21 Nov 2025, 20:05.

Change

  • Previous filing in this sequence was filed on 04 Nov 2025.
  • Current net transaction value: -$2,284,766.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001680739 Primary reporting owner

Baynes Roy D.

Relationship
Director
Address
C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN
Signature
/s/ Vincent Fontanilla, Attorney-in-Fact
Signature date
21 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Options Exercise

Transaction value
$209,234
Shares
+5,112
Change %
+28%
Price
$40.93
Shares after
23,471
Date
19 Nov 2025
Ownership
Direct
NTRA transaction

Common Stock

Sale

Transaction value
$266,839
Shares
-1,250
Change %
-5.3%
Price
$213.47
Shares after
22,221
Date
19 Nov 2025
Ownership
Direct
Footnotes
F1, F2
NTRA transaction

Common Stock

Sale

Transaction value
$370,946
Shares
-1,727
Change %
-7.8%
Price
$214.79
Shares after
20,494
Date
19 Nov 2025
Ownership
Direct
Footnotes
F1, F3
NTRA transaction

Common Stock

Sale

Transaction value
$461,304
Shares
-2,135
Change %
-10%
Price
$216.07
Shares after
18,359
Date
19 Nov 2025
Ownership
Direct
Footnotes
F1, F4
NTRA transaction

Common Stock

Options Exercise

Transaction value
$24,558
Shares
+600
Change %
+3.3%
Price
$40.93
Shares after
18,959
Date
20 Nov 2025
Ownership
Direct
NTRA transaction

Common Stock

Options Exercise

Transaction value
$291,131
Shares
+7,068
Change %
+37%
Price
$41.19
Shares after
26,027
Date
20 Nov 2025
Ownership
Direct
NTRA transaction

Common Stock

Sale

Transaction value
$260,646
Shares
-1,184
Change %
-4.5%
Price
$220.14
Shares after
24,843
Date
20 Nov 2025
Ownership
Direct
Footnotes
F1, F5
NTRA transaction

Common Stock

Sale

Transaction value
$199,632
Shares
-900
Change %
-3.6%
Price
$221.81
Shares after
23,943
Date
20 Nov 2025
Ownership
Direct
Footnotes
F1, F6
NTRA transaction

Common Stock

Sale

Transaction value
$401,220
Shares
-1,800
Change %
-7.5%
Price
$222.90
Shares after
22,143
Date
20 Nov 2025
Ownership
Direct
Footnotes
F1, F7
NTRA transaction

Common Stock

Sale

Transaction value
$425,417
Shares
-1,900
Change %
-8.6%
Price
$223.90
Shares after
20,243
Date
20 Nov 2025
Ownership
Direct
Footnotes
F1, F8
NTRA transaction

Common Stock

Sale

Transaction value
$423,685
Shares
-1,884
Change %
-9.3%
Price
$224.89
Shares after
18,359
Date
20 Nov 2025
Ownership
Direct
Footnotes
F1, F9

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-5,112
Change %
-89%
Price
$0.000000
Shares after
600
Date
19 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,112
Exercise price
$40.93
Footnotes
F10
NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-600
Change %
-100%
Price
$0.000000
Shares after
0
Date
20 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
600
Exercise price
$40.93
Footnotes
F10
NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-7,068
Change %
-100%
Price
$0.000000
Shares after
0
Date
20 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,068
Exercise price
$41.19
Footnotes
F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 10 footnotes

Footnote F1

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.18 to $214.1550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.35 to $215.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.55 to $216.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.00 to $220.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.42 to $222.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.46 to $223.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F8

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.49 to $224.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F9

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.72 to $224.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F10

The option shares are fully exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .